P2.02-009 Metabolomic Analysis in Lung Cancer
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2017.09.1186
Abstract: a median OS of not reached so far and 14.6 months respectively (P1⁄40.20). Conclusion: STK11 mutations represent a distinct subset of NSCLC. NGS showed that STK11 mutations commonly co-existed with other driver genes. Our results… read more here.
Keywords: stk11 mutations; 009 metabolomic; lung cancer; metabolomic analysis ... See more keywords